The Global Health Innovative Technology (GHIT) Fund: financing medical innovations for neglected populations by BT Slingsby, Kiyoshi Kurokawa

Get full text

COVID‐19 outbreak on the Diamond Princess Cruise Ship in February 2020 by Yasuharu Tokuda, Tomoko Sakihama, Makoto Aoki, Kiyosu Taniguchi, Gautam A. Deshpande, Satoshi Suzuki, Sakon Uda, Kiyoshi Kurokawa

Get full text

Authors’ reply: Independent investigation may be more reliable in the event with political nature by Yasuharu Tokuda, Tomoko Sakihama, Makoto Aoki, Kiyosu Taniguchi, Gautam A. Deshpande, Satoshi Suzuki, Sakon Uda, Kiyoshi Kurokawa

Get full text

Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis by Kiyoshi Kurokawa, Keishi Abe, Takao Saruta, Masaaki Arakawa, Ryuichi Kikkawa, Naohiko Ueda, Kaoru Onoyama, Kimio Tomita, Nobuya Ogawa

Get full text

Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan. by Yasuo Imanishi, Shingo Fukuma, Angelo Karaboyas, Bruce M Robinson, Ronald L Pisoni, Takanobu Nomura, Takashi Akiba, Tadao Akizawa, Kiyoshi Kurokawa, Akira Saito, Shunichi Fukuhara, Masaaki Inaba

Get full text

The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) by Barry M Brenner, Mark E Cooper, Dick de Zeeuw, Jean-Pierre Grunfeld, William F Keane, Kiyoshi Kurokawa, Janet B McGill, William E Mitch, Hans Henrik Parving, Guiseppe Remuzzi, Arthur B Ribeiro, Mark D Schluchter, Duane Snavely, Zhongxin Zhang, Roger Simpson, Denise Ramjit, Shahnaz Shahinfar, RENAAL Study Investigators

Get full text